Zai Lab Limited announced that the 2023 National Reimbursement Drug List released by China’s National Healthcare Security Administration has been updated to include the following medicines and indications.
BioArctic AB’s partner Eisai announced that LEQEMBI will be launched in Japan on December 20, following its scheduled inclusion in the price listing on the Japan National Health Insurance drug price list.
LEQEMBI® to be launched in Japan for Alzheimer’s disease on December 20 Read More »
Inspirándose en algunas estructuras vegetales y su funcionamiento en las plantas, unos científicos han conseguido una mejora decisiva en el diseño de actuadores fototérmicos programables, a base de metales líquidos, para robots blandos. Ciertos metales l&i …
No sucedió en el vecindario de la Tierra, sino en el de Marte, pero el fenómeno fue espectacular e inesperado. Una investigación al respecto ha concluido y sus resultados se han hecho públicos recientemente. En diciembre de 2022, la sonda espacial MAVEN (Mars Atm …
La relatividad general y la mecánica cuántica son las dos descripciones más fundamentales que tenemos de la naturaleza. La relatividad general explica la gravedad a gran escala, mientras que la mecánica cuántica explica el comportamiento de átomos y mol&eacu …
HUTCHMED (China) Limited (Nasdaq/AIM:HCM, HKEX:13) (“HUTCHMED”) today announces that it has completed enrollment of its Phase II/III trial of fruquintinib in combination with sintilimab as second-line treatment for locally advanced or metastatic renal cell carcinoma (“RCC”) in China.
Even before its billionaire owner made recent headlines by endorsing an antisemitic post and hurling an expletive at advertisers, biopharma companies had begun to find different uses for their advertisement budgets.
In Musk Era, Pharma Companies Move Ads Away From X Read More »
Engaged Capital is opposed to Nevro going after acquisitions that may jeopardize its core business, Bloomberg reported Monday.
Activist investor takes stake in Nevro amid struggles to grow neuromodulation sales Read More »
Hospitals have lobbied against the site-neutral payment policies included in the bipartisan legislation.
House passes bill targeting price transparency, site-neutral payments, PBMs Read More »
Five Qualified Health Information Networks, or QHINs, completed the onboarding process and are ready for data exchange, with more companies in the pipeline.
TEFCA goes live in ‘Big Bang’ for health data exchange Read More »
